Details

Autor(en) / Beteiligte

• D'Amico, Francesco, PhD
• Rehill, Amritpal, BSc
• Knapp, Martin, PhD
• Aguirre, Elisa, PhD
• Donovan, Helen, DClinPsych
• Hoare, Zoe, PhD
• Hoe, Juanita, PhD
• Russell, Ian, DSc
• Spector, Aimee, PhD, DClinPsy
• Streater, Amy, MSc
• Whitaker, Christopher, MSc
• Woods, Robert T., MA, MSc
• Orrell, Martin, PhD, FRCPsych

Titel

Maintenance Cognitive Stimulation Therapy: An Economic Evaluation Within a Randomized Controlled Trial

Ist Teil von

• Journal of the American Medical Directors Association, 2015, Vol.16 (1), p.63-70

Ort / Verlag

United States: Elsevier Inc

Erscheinungsjahr

2015

Link zum Volltext

Quelle

MEDLINE

Beschreibungen/Notizen

• Abstract Background Cognitive Stimulation Therapy (CST) is effective and cost-effective for people with mild-to-moderate dementia when delivered biweekly over 7 weeks. Aims To examine whether longer-term (maintenance) CST is cost-effective when added to usual care. Methods Cost-effectiveness analysis within multicenter, single-blind, pragmatic randomized controlled trial; subgroup analysis for people taking acetylcholinesterase inhibitors (ACHEIs). A total of 236 participants with mild-to-moderate dementia received CST for 7 weeks. They were randomized to either weekly maintenance CST added to usual care or usual care alone for 24 weeks. Results Although outcome gains were modest over 6 months, maintenance CST appeared cost-effective when looking at self-rated quality of life as primary outcome, and cognition (MMSE) and proxy-rated quality-adjusted life years as secondary outcomes. CST in combination with ACHEIs offered cost-effectiveness gains when outcome was measured as cognition. Conclusions Continuation of CST is likely to be cost-effective for people with mild-to-moderate dementia.